PARPARADIGM BIOPHARMACEUTICALS LIMITED..Market sensitive

Paradigm Receives $5.75m R&D Tax Incentive Refund

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFPAR announcement history

Recent PAR announcements